News
ELFBAR; LOST MARY: ELFBAR and LOST MARY lead up product innovations at World Vape Show 2025 in Dubai
ELFBAR King Series, industry's fullest innovative lineup with all-inclusive adjustable features, on displayNext-generation automated production capabilities shownUser experience enhanced through ...
ACB Achieves Record Annual Global Medical Cannabis Net Revenue1 of $244.4 million, representing 39% YoY growth Delivers Record Adjusted EBITDA1 of ...
Enterprise-ready Solution Bridges the Gap from AI Experimentation to Full-Scale TransformationSAN ANTONIO, June 18, 2025) services and Rackspace's application management expertise with Sema4.ai's adva ...
What happens when the internet's biggest streamers go live for 71 straight hours with more than 120 creators streaming simultaneously? You get ...
LOS ALAMITOS, CALIFORNIA / ACCESS Newswire / June 18, 2025 / Millions of adults in the U.S. live with obstructive sleep apnea (OSA), yet many remain undiagnosed. In Los Alamitos and throughout Orange ...
Clear Start Tax Urges Families and Entrepreneurs to Act Before IRS Liens Create Long-Term Financial Consequences IRVINE, CA / ACCESS Newswire / June 18, 2025 / Many Americans think of back taxes as a ...
Tocvan has outlined a detailed plan for a 50,000-tonne pilot facility at its 100% controlled Gran Pilar Gold-Silver Project in Sonora, Mexico, featuring a 1.76-hectare ...
With more than 10,000 procedures performed, Dr. Naderi discusses the technical demands and aesthetic advantages of non-surgical rhinoplasty using dermal fillers. CHEVY CHASE, MD / ACCESS Newswire / Ju ...
Metacon has successfully completed subscription and received payment in the warrant program resolved by the Annual General Meeting on May 27. There has ...
Tickle transitions from interim role to permanent position, bringing 30 years of global sales experience to continue driving the company's growthSAN MATEO, Calif., June 18, 2025,as Chief of Global Fie ...
Regulatory Approval by the UK Financial Conduct Authority was Key Requirement for Transaction TimingMinimal Conditions Remain for Deal Completion; Closing Expected in July, 2025 AUSTIN, TX AND NOTTING ...
Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the ped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results